(MENAFN- Baystreet) Exact Science Cops Gallup Award
Moderna Loses Ground on New Product News
FDA Greenlights Merck for Lung Treatment
Wednesday's Stock Watch Includes DJT, Reddit, and Alibaba
These Are the Biggest Mid-Week Trades Previous Articles Subscribe to Get Small Cap News & Alerts Baystreet Staff - Wednesday, March 27, 2024
UniFirst Advances on Q4 Numbers
UniFirst Corporation (NYSE: UNF) shares jumped mid-week Wednesday, soon after the company reported results for its second quarter ended February 24, 2024 as compared to the corresponding period in the prior fiscal year:
Consolidated revenues for the second quarter increased 8.8% to $590.7 million. Operating income jumped 34.9% ti $27.9 million.
Net income increased to $20.5 million from $17.8 million in the prior year, or 14.9%. EBITDA increased to $62.5 million compared to $50.5 million in the prior year, or 23.8%.
The Company's financial results for the second quarter of fiscal 2024 and 2023 included approximately $3.2 million and $9.1 million, respectively, of costs directly attributable to its customer relationship management computer system, enterprise resource planning system and branding initiatives. In addition, the Company incurred costs related to the acquisition of Clean Uniform during the second quarter of fiscal 2023 of approximately $2.0 million. The effect of these items on the second quarter of fiscal 2024 and 2023 combined to decrease.
Operating income fell $3.2 million and EBITDA by $11.1 million. Net income by $2.5 million and $8.3 million, respectively. Diluted earnings per share by $0.13 and $0.44, respectively.
UNF shares popped $4.38, or 2.6%, to $171.53.
About Us Contact Us Advertise License Our Content Jobs Disclaimer Privacy Policy
Copyright 1998 - 2024 Baystreet Media Corp. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes. Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Market Data is provided by QuoteMedia. Earnings by Zacks. Analyst Ratings by Zacks
MENAFN27032024000212011056ID1108029704
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.